Inogen registers for $86M IPO
Oxygen therapy device maker Inogen registers for an initial public offering worth up to $86.3 million.
Inogen registered for an initial public offering worth up to $86.3 million IPO, saying it plans to will trade on the NASDAQ exchange under the INGN symbol.
The Goleta, Calif.-based medical device company makes oxygen concentrators used to deliver supplemental oxygen therapy to patients suffering from chronic respiratory conditions.
Inogen has yet to determine the number of shares it will offer, or their price range, according to a regulatory filing.